SCM
ORKA

Sterling Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Sterling Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Sell
177
-1,101
-86% -$73.4K ﹤0.01% 1964
2026
Q1 		$62.7K Sell
1,278
-946
-43% -$32.9K ﹤0.01% 1548
2025
Q4 		$67.4K Buy
2,224
+347
+18% +$9.67K ﹤0.01% 1684
2025
Q3 		$36.1K Buy
1,877
+1,143
+156% +$16.9K ﹤0.01% 1879
2025
Q2 		$8.23K Buy
+734
New +$7.65K ﹤0.01% 2253

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sterling Capital Management's ORKA Position: Q2 2026 in Review

Sterling Capital Management reduced its Oruka Therapeutics (ORKA) stake by 86% in Q2 2026, selling an estimated $73.4K and leaving 177 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Sterling Capital Management first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. The position peaked at $67.4K in Q4 2025. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Sterling Capital Management held 177 shares of Oruka Therapeutics worth $16.8K as of Q2 2026.
  • Sterling Capital Management sold 1,101 Oruka Therapeutics shares in Q2 2026, an estimated $73.4K.
  • Oruka Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1964 holding.
  • Sterling Capital Management first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Oruka Therapeutics position peaked at $67.4K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.